Zhuhai Sailong Pharmaceutical Co Ltd (002898) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.062x

Based on the latest financial reports, Zhuhai Sailong Pharmaceutical Co Ltd (002898) has a cash flow conversion efficiency ratio of -0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-28.66 Million ≈ $-4.19 Million USD) by net assets (CN¥460.47 Million ≈ $67.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002898 company net worth for the company's overall valuation and market capitalisation.

Zhuhai Sailong Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Zhuhai Sailong Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhuhai Sailong Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhuhai Sailong Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore how high is Zhuhai Sailong Pharmaceutical Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Culpeo Minerals Ltd AU:CPO	-0.105x
Adaptimmune Therapeutics Plc NASDAQ:ADAP	0.490x
Finsbury Growth & Income Trust LSE:FGT	0.005x
Hemostemix Inc V:HEM	0.839x
ESSA Pharma Inc NASDAQ:EPIX	-0.039x
Viking Mines Ltd AU:VKA	-0.290x
Af Legal Group Ltd AU:AFL	-0.015x
Langgeng Makmur Industri Tbk JK:LMPI	0.228x

Annual Cash Flow Conversion Efficiency for Zhuhai Sailong Pharmaceutical Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2025. View 002898 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥384.15 Million ≈ $56.21 Million	CN¥19.06 Million ≈ $2.79 Million	0.050x	+163.74%
2024-12-31	CN¥499.28 Million ≈ $73.06 Million	CN¥-38.86 Million ≈ $-5.69 Million	-0.078x	-216.81%
2023-12-31	CN¥535.88 Million ≈ $78.42 Million	CN¥35.71 Million ≈ $5.23 Million	0.067x	+148.30%
2022-12-31	CN¥526.35 Million ≈ $77.02 Million	CN¥14.12 Million ≈ $2.07 Million	0.027x	-57.35%
2021-12-31	CN¥563.66 Million ≈ $82.48 Million	CN¥35.46 Million ≈ $5.19 Million	0.063x	+21040.16%
2020-12-31	CN¥587.00 Million ≈ $85.90 Million	CN¥174.69K ≈ $25.56K	0.000x	+100.42%
2019-12-31	CN¥659.02 Million ≈ $96.44 Million	CN¥-46.52 Million ≈ $-6.81 Million	-0.071x	-1507.08%
2018-12-31	CN¥663.54 Million ≈ $97.10 Million	CN¥3.33 Million ≈ $487.06K	0.005x	-96.35%
2017-12-31	CN¥618.64 Million ≈ $90.53 Million	CN¥85.13 Million ≈ $12.46 Million	0.138x	-55.48%
2016-12-31	CN¥254.45 Million ≈ $37.23 Million	CN¥78.65 Million ≈ $11.51 Million	0.309x	+38.92%
2015-12-31	CN¥213.20 Million ≈ $31.20 Million	CN¥47.44 Million ≈ $6.94 Million	0.223x	-39.11%
2014-12-31	CN¥140.55 Million ≈ $20.57 Million	CN¥51.36 Million ≈ $7.52 Million	0.365x	-36.90%
2013-12-31	CN¥111.97 Million ≈ $16.38 Million	CN¥64.84 Million ≈ $9.49 Million	0.579x	--

About Zhuhai Sailong Pharmaceutical Co Ltd

SHE:002898 China Biotechnology

Market Cap

$9.53 Million

CN¥65.12 Million CNY

Market Cap Rank

#27288 Global

#4746 in China

Share Price

CN¥0.37

Change (1 day)

-2.63%

52-Week Range

CN¥0.32 - CN¥14.70

All Time High

CN¥29.47